Identifies atherosclerotic plaque clusters correlating with myocardial dysfunction in high-risk individuals, suggesting new insights into CAD progression.
Objectives: Although coronary artery disease (CAD) involves progressive atherosclerotic plaque dysfunction, further characterization of different cluster profiles and their impact on myocardial function has not been fully explored.Therefore, this study's pilot aim is to identify data-driven atherosclerotic plaque clusters using coronary computed tomography angiography and correlate types with dysfunction observed by positron emission tomography/computed tomography (PET-CT).Methods: Myocardial perfusion study images of subjects with a high clinical risk of developing CAD were analyzed with semi-automated atherosclerotic plaque characterization.The K-mean clustering method was performed to detect coronary atherosclerotic plaques.An atherosclerotic plaque score was assigned to each subject according to their arteries cluster profiles and was correlated with a principal component analysis (PCA) score that evaluated myocardial perfusion, volumes, and synchrony from PET-CT.Results: Three well-differentiated clusters were identified from 95 coronary atherosclerotic plaques of 35 subjects.Cluster 1 (28.2%) was characterized by a high fibro-necrotic atherosclerotic plaque, cluster 2 (59.7%) by predominantly fibrous atherosclerotic plaque, and cluster 3 (11.9%)by a necro-calcified atherosclerotic plaque.The atherosclerotic plaque score displayed a significant correlation with the first (r = 0.42; 95% confidence interval [CI]: 0.049-0.675,p = 0.012) and third (r = 0.36; 95% CI: 0.036-0.626,p = 0.035) PCA score components.These were comprised parameters related to impairments in ventricular volume capacity, mechanical dyssynchrony, filling rates, and calcium scores in PET-CT evaluation.Conclusions: The atherosclerotic plaque clusters identified in this study could provide a pathophysiological explanation of CAD progression and potentially lead to a better characterization of the developing disease.
No takes yet. Share an insight, caveat, or question.
Alexanderson-Rosas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: